2010-11-15 – Page 5 – China Stock Advice

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page Number PART I.FINANCIAL INFORMATION Item 1. Financial Statements 4nsolidated Balance Sheets of September 30, 2010 (unaudited) and December 31, 2009 4nsolidated Statements of Operations and Othermprehensiveome (Loss) for the Three Months and Nine Months Ended September 30, 2010 and 2009 (unaudited)] [CERTIFICATE OF AMENDMENT AND CERTIFICATE OF CHANGE v202562_ex3-1.htm 3 EX-3.1] [CERTIFICATION I, Weibing Lu, certify that: 1.I have reviewed this Quarterly 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to] [CERTIFICATION I, Michael H. Lan, certify that: 1.I have reviewed this Quarterly 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect] [CERTIFICATION (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer v202562_ex32-1.htm 37 EX-32.1] [CERTIFICATION (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Michael H. Lan Chief Financial Officer (Principal Financial and Accounting Officer) v202562_ex32-2.htm 38 EX-32.2]

By info| 2016-02-05T03:55:47+00:00 November 15th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 10-Q, 2010-11-15, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

GIGM [GIGAMEDIA] CORRESP: November 15, 2010 VIA FACSIMILE AND EDGAR Ms.

[November 15, 2010 VIA FACSIMILE AND EDGAR Ms. Kathleen Collins Accounting Branch Chief Division of Corporation Finance One Station Place 100 F Street N.E. Re: GigaMedia Limited Form 20-F for the Fiscal Year Ended December 31, 2009 Filed June 30, 2010 File No. 0-30540 Dear Ms. Collins: Form 20-F for the Fiscal Year Ended December 31, 2009 Item 3. Key]

By info| 2016-03-10T05:52:27+00:00 November 15th, 2010|Categories: Chinese Stocks, GIGM, Webplus ver|Tags: 0001105101, 2010-11-15, 7370, CORRESP, GIGM, SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC.|0 Comments

KNDI [Kandi Technologies] 10-Q: (Original Filing)

[(86 - 0579) 82239856 þ ¨ þ ¨ ¨ Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer þ Smaller reporting company ¨ þ Yes TABLE OF CONTENTS Page PART I— FINANCIAL INFORMATION Item 1. Condensed Consolidated Financial Statements 1 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations] [Joint Venture Agreement th The “Agreement” was made on the 28 Party A: Jinhua Bada Group (Address: 480 Liberation West Road, Jinhua City, Zhejiang Province, China) Party B: Zhejiang Kandi Vehicles Co., Ltd Party C: Tianneng Power International Co., Ltd. (Address: Meishan Industrial Zone, Changxing City, Zhejiang Province, China) nergy conservation” and “ emission reduction” The Chinese government has recently] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Hu Xiaoming, certify that: 1. 2. 3. 4. (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 1. 2. 3. 4. (a) (b) (c) (d) 5. (a) (b) Zhu Xiaoying Chief Financial Officer EX-31.2 4 v202496_ex31-2.htm] [18 U.S.C. § 1350, § 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Hu Xiaoming President and Chief Executive Officer November 15, 2010 Zhu Xiaoying Chief Financial Officer November 15, 2010 EX-32.1 5 v202496_ex32-1.htm]

By info| 2016-03-18T16:44:43+00:00 November 15th, 2010|Categories: Chinese Stocks, KNDI, SEC Original|Tags: 0001316517, 10-Q, 2010-11-15, 3711, KNDI, MOTOR VEHICLES and PASSENGER CAR BODIES|0 Comments

THTI [THT Heat Transfer Technology] DEF 14C: SCHEDULE 14C INFORMATION Check the appropriate box: [_]

[SCHEDULE 14C INFORMATION Check the appropriate box: [_] Preliminary Information Statement [X] Definitive Information Statement THT HEAT TRANSFER TECHNOLOGY, INC. Payment of Filing Fee (Check the appropriate box): [x] No Fee Required (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (4) Proposed maximum aggregate value of transaction: (5)]

By info| 2016-03-22T20:37:04+00:00 November 15th, 2010|Categories: Chinese Stocks, THTI, Webplus ver|Tags: 0001375686, 2010-11-15, 3443, DEF_14C, FABRICATED PLATE WORK (BOILER SHOPS), THTI|0 Comments

BORN [CHINA NEW BORUN] 6-K: QuickLinks — Click here to rapidly navigate through

[QuickLinks -- Click here to rapidly navigate through this document CHINA NEW BORUN CORPORATION Notice is hereby given that China New Borun Corporation, a Cayman Islands company (the "Company"), will hold its annual general meeting of shareholders at 3:00 p.m., local time, on December 21, 2010 (the "Annual General Meeting"), at the Company's corporate offices located at Bohai Industrial Park] [QuickLinks -- Click here to rapidly navigate through this document CHINA NEW BORUN CORPORATION PROXY STATEMENT General Our board of directors is soliciting proxies for the annual general meeting of shareholders to be held on December 21, 2010 at 3:00 p.m., local time, or at any adjournment or postponement thereof (the "Annual General Meeting"). The Annual General Meeting will be] [QuickLinks -- Click here to rapidly navigate through this document FORM OF PROXY CARD FOR RECORD HOLDERS OF ORDINARY SHARES "Company" For Against Abstain Proposal 1: As an ordinary resolution, THAT Rong Chen be elected as a director of the Company, to hold office until the close of the next annual general meeting of shareholders of the Company, or his] [QuickLinks -- Click here to rapidly navigate through this document Annual General Meeting of China New Borun Corporation ý Please make your marks like this: For Against Abstain 1. Election of Rong Chen as a director of the Company. o o o 2. Election of Jinmiao Wang as a director of the Company. o o o 3. Election of Raymond] [FORM 6-K China New Borun Corporation Bohai Industrial Park ý o o o o ý China New Borun Corporation TABLE OF CONTENTS Notice of Annual General Meeting of Shareholders dated November 15, 2010 Proxy Statement dated November 15, 2010 Form of Proxy Card for Record Holders of Ordinary Shares Form of Voting Instruction Card for Record Owners of American Depositary]

By info| 2016-04-02T15:43:18+00:00 November 15th, 2010|Categories: BORN, Chinese Stocks, Webplus ver|Tags: 0001490366, 2010-11-15, 2082, 6-K, BORN, MALT BEVERAGES|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page Number PART I.FINANCIAL

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page Number PART I.FINANCIAL INFORMATION Item 1. Financial Statements 4nsolidated Balance Sheets of September 30, 2010 (unaudited) and December 31, 2009 4nsolidated Statements of Operations and Othermprehensiveome (Loss) for the Three Months and Nine Months Ended September 30, 2010 and 2009 (unaudited)] [CERTIFICATE OF AMENDMENT AND CERTIFICATE OF CHANGE v202562_ex3-1.htm 3 EX-3.1] [CERTIFICATION I, Weibing Lu, certify that: 1.I have reviewed this Quarterly 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to] [CERTIFICATION I, Michael H. Lan, certify that: 1.I have reviewed this Quarterly 2.Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect] [CERTIFICATION (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Weibing Lu Chief Executive Officer v202562_ex32-1.htm 37 EX-32.1] [CERTIFICATION (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Michael H. Lan Chief Financial Officer (Principal Financial and Accounting Officer) v202562_ex32-2.htm 38 EX-32.2]

By info| 2016-02-05T03:56:37+00:00 November 15th, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: 0001076939, 10-Q, 2010-11-15, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

HOLI [Hollysys Automation Technologies] 6-K: (Original Filing)

[Hollysys Automation Technologies Announces US$ 30.45 Million 300-350km/h High-speed Rail ATPs Contract Win Beijing, China – November 15, 2010 – Hollysys Automation Technologies, Ltd. (NASDAQ: HOLI) The high-speed rail signaling system is mainly consisted of two products, one is on-board ATP (Automatic Train Protection) which is installed at the front and tail end of each train, the other is ground-based]

By info| 2016-03-10T11:06:48+00:00 November 15th, 2010|Categories: Chinese Stocks, HOLI, SEC Original|Tags: 0001357450, 2010-11-15, 3620, 6-K, ELECTRICAL INDUSTRIAL APPARATUS, HOLI|0 Comments

KNDI [Kandi Technologies] 10-Q: (86 – 0579) 82239856 þ ¨ þ ¨

[(86 - 0579) 82239856 þ ¨ þ ¨ ¨ Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer þ Smaller reporting company ¨ þ Yes TABLE OF CONTENTS Page PART I— FINANCIAL INFORMATION Item 1. Condensed Consolidated Financial Statements 1 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations] [Joint Venture Agreement th The “Agreement” was made on the 28 Party A: Jinhua Bada Group (Address: 480 Liberation West Road, Jinhua City, Zhejiang Province, China) Party B: Zhejiang Kandi Vehicles Co., Ltd Party C: Tianneng Power International Co., Ltd. (Address: Meishan Industrial Zone, Changxing City, Zhejiang Province, China) nergy conservation” and “ emission reduction” The Chinese government has recently] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Hu Xiaoming, certify that: 1. 2. 3. 4. (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 1. 2. 3. 4. (a) (b) (c) (d) 5. (a) (b) Zhu Xiaoying Chief Financial Officer EX-31.2 4 v202496_ex31-2.htm] [18 U.S.C. § 1350, § 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Hu Xiaoming President and Chief Executive Officer November 15, 2010 Zhu Xiaoying Chief Financial Officer November 15, 2010 EX-32.1 5 v202496_ex32-1.htm]

By info| 2016-03-18T16:45:31+00:00 November 15th, 2010|Categories: Chinese Stocks, KNDI, Webplus ver|Tags: 0001316517, 10-Q, 2010-11-15, 3711, KNDI, MOTOR VEHICLES and PASSENGER CAR BODIES|0 Comments

SVA [SINOVAC BIOTECH] SC 13G: (Original Filing)

[Joint Filing Agreement SAIF Partners IV L.P. Andrew Y. Yan Director of SAIF IV GP Capital Ltd., which is the General Partner of SAIF IV GP, L.P., which is the General Partner of SAIF Partners IV L.P. SAIF IV GP, L.P. Andrew Y. Yan Director of SAIF IV GP Capital Ltd., which is the General Partner of SAIF IV GP,] [CUSIP No. P8696W104 Page 2 of 9 1 NAMES OF REPORTING PERSONS 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) o (a) þ (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands 5]

By info| 2016-03-24T02:34:35+00:00 November 15th, 2010|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2010-11-15, 2834, PHARMACEUTICAL PREPARATIONS, SC_13G, SVA|0 Comments

WX [WuXi PharmaTech (Cayman)] SC 13G: (Original Filing)

[securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be (Continued on the Following Pages) 1. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Kylin Fund LP 2. 3. 4. Delaware]

By info| 2016-04-02T18:55:56+00:00 November 15th, 2010|Categories: Chinese Stocks, SEC Original, WX|Tags: 0001403132, 2010-11-15, 2834, PHARMACEUTICAL PREPARATIONS, SC_13G, WX|0 Comments